Vertex Pharmaceuticals Incorporated

VRTX · Moat type: REGULIERUNG
MoatScore
8/10
Fair Value
461 USD
Margin of Safety
-14.5 %
Rating
BEOBACHTEN
GESCHÄFTSMODELL Vertex Pharmaceuticals develops and markets patent-protected medications for treating rare genetic diseases—particularly cystic fibrosis (CF)—and generates revenue almost exclusively through global sales of these prescription-only specialty pharmaceuticals.
View full analysis →
🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.